No black box warning on record for Monjuvi
As of the latest FDA labeling reviewed, Monjuvi (TAFASITAMAB-CXIX) does not carry a black box warning. Standard warnings and precautions still apply — see the full Monjuvi medicine page for the complete safety profile.